ページ本文へ移動
pepts.wiki

私たちは医師ではなく、ここにある内容は医療上の助言ではありません。必ず先に医療専門家に相談してください。 この表示をする理由

英語からの機械翻訳です。英語版が基準です。 英語で読む

未整理Stub

Adamax

セマックス改変類似体

研究用サプライヤーが、Semaxの修飾類似体として販売している。この化合物に関する発表された研究は見つからなかった。

再構成計算機

概要

未整理

このウィキでは、この化合物の位置づけがまだ定まっていません。化合物に関するいかなる主張も慎重に扱ってください。

このページは作成途中です

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

取り扱いと溶解

粉末から測定された試料まで

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. バイアルのラベルを読む

    ラベルには、バイアル内のペプチドの質量がミリグラム単位で記載されています。この数値が、すべての計算の出発点です。

  2. 2. 希釈液を加える

    計量した量の希釈液を、ガラス壁を伝わせてゆっくり加えます。やさしく回し混ぜてください。振るとペプチドを損なうおそれがあります。

  3. 3. 濃度を求める

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. 試料の量を測る

    必要な体積は、必要な質量を濃度で割ったものです。U-100注射器では、1 mLが100単位です。

以下の計算機で計算を行い、その過程を表示します。

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on Adamax itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Adamax; no amount here is a recommendation.

Adamax: PubMedで

What PubMed held for Adamax on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

40
papers
14
in humans
0
clinical trials
0
randomized trials
2012: 0 papers122013: 0 papers2014: 0 papers142015: 0 papers2016: 0 papers162017: 0 papers2018: 0 papers182019: 1 papers2020: 3 papers202021: 1 papers2022: 4 papers222023: 7 papers2024: 7 papers242025: 12 papers2026: 8 papers so far26
Papers per year, 2012 to 2026. The most in one year: 12.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Effective skin cancer classification by modified and optimized inception-ResNet-V2 model

    StudyUmapathi K, Vanithamani R, Priya L, et al. Scientific reports, 2025. PMID 41266780

  2. Indoor surface classification for mobile robots

    StudyDemirtaş A, Erdemir G, Bayram H PeerJ. Computer science, 2024. PMID 38259883

  3. A two-stage renal disease classification based on transfer learning with hyperparameters optimization

    StudyBadawy M, Almars AM, Balaha HM, et al. Frontiers in medicine, 2023. PMID 37089598

  4. Mine Gas Concentration Forecasting Model Based on an Optimized BiGRU Network

    StudyLiang R, Chang X, Jia P, et al. ACS omega, 2020. PMID 33195909

  5. Optimizing home energy management: Robust and efficient solutions powered by attention networks

    StudyNutakki M, Mandava S Heliyon, 2024. PMID 38434054

  6. Leveraging electrocardiography signals for deep learning-driven cardiovascular disease classification model

    StudyAlqahtani H, Aldehim G, Alruwais N, et al. Heliyon, 2024. PMID 39224246

Search used: ("Adamax"[tiab]). Run it on PubMed

研究リンク

Also in Cognitive